Eli Lilly and Company (NYSE:LLY) will participate in the Citi's 2025 Global Healthcare Conference on December 2, 2025. Ilya ...

Alzheimer’s drug donanemab approved for use by drug regulator, likely to be available in India next year ...

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

A GLP-1/glucagon dual agonist induced significant weight loss and improved multiple cardiometabolic parameters for adults ...

Major stock indexes ended sharply lower to begin the week, which will see AI darling Nvidia and retail giants report ...

Oz called the calculation "our estimate based on company numbers," referring to Lilly and Novo Nordisk, the makers of the ...

As he discussed Amgen, it was unsurprising that weight loss drug giant Eli Lilly and Company (NYSE:LLY) also caught Cramer’s ...

Let’s delve into the details of each of the evaluated factors, but first, for a quick background: With a $917 Bil market cap, ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Dow Jones Top Company Headlines at 7 AM ET: Home Depot Cuts Outlook As Home Improvement Slowdown Continues | Roche ... Home Depot reported lower third-quarter profit and lowered its full-year outlook ...

Here’s what else you need to know to get up to speed and on with your day. 1️⃣ Border Patrol. Border Patrol agents have ...

Vanda's Tradipitant Study Success Positions it as Key Adjunct in $50B+ Global GLP-1 Agonist Market WASHINGTON, Nov. 17, 2025 /PRNewswire/ -- Vanda Pharmaceuticals ...